We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
-18.72%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$852M
AUM Growth
-$2.71B
(-76%)
Cap. Flow
-$2.35B
Cap. Flow
% of AUM
-275.82%
Top 10 Holdings %
Top 10 Hldgs %
41.33%
Holding
1,001
New
100
Increased
48
Reduced
168
Closed
613
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$5.75M |
| 2 |
EOG Resources
EOG
|
+$5.23M |
| 3 |
SLB Ltd
SLB
|
+$4.59M |
| 4 |
ConocoPhillips
COP
|
+$1.85M |
| 5 |
PennyMac Financial
PFSI
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$24.8M |
| 2 |
Bausch Health
BHC
|
+$12.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$12.3M |
| 4 |
Netflix
NFLX
|
+$10.3M |
| 5 |
TriNet
TNET
|
+$9.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.87% |
| 2 | Energy | 1.43% |
| 3 | Technology | 0.91% |
| 4 | Real Estate | 0.26% |
| 5 | Communication Services | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
301
CALL
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $139K | 0.02% |
+5,000
| New | +$203K |
|
|
ICPT
302
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $138K | 0.02% |
+10,000
| New | +$160K |
|
|
PLYA
303
CALL
DELISTED
Playa Hotels & Resorts
PLYA
| $137K | 0.02% |
20,000
| – | – |
|
304
PUT
Immunic
IMUX
$191M
| $129K | 0.02% |
3,710
+1,710
| +86% | +$110K |
|
305
CALL
TG Therapeutics
TGTX
$8.19B
| $127K | 0.01% |
29,900
-25,500
| -46% | -$159K |
|
306
Box
BOX
$4.31B
| $126K | 0.01% |
5,000
| – | – |
|
307
Teva Pharmaceuticals
TEVA
$41.2B
| $123K | 0.01% |
16,350
-68,650
| -81% | -$598K |
|
|
MNTV
308
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $122K | 0.01% |
13,900
-41,100
| -75% | -$550K |
|
309
EQT Corp
EQT
$33B
| $120K | 0.01% |
+3,500
| New | +$144K |
|
|
IEA
310
CALL
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $120K | 0.01% |
15,000
+10,000
| +200% | +$93.5K |
|
311
CALL
Ginkgo Bioworks
DNA
$528M
| $119K | 0.01% |
1,250
-1,500
| -55% | -$183K |
|
312
PUT
Cytokinetics
CYTK
$10.9B
| $118K | 0.01% |
+3,000
| New | +$121K |
|
|
313
CALL
Immunic
IMUX
$191M
| $114K | 0.01% |
3,280
-2,900
| -47% | -$186K |
|
314
PUT
MannKind Corp
MNKD
$1.27B
| $114K | 0.01% |
+30,000
| New | +$110K |
|
315
PUT
Avita Medical
RCEL
$138M
| $112K | 0.01% |
23,500
| – | – |
|
|
OSH
316
DELISTED
Oak Street Health, Inc.
OSH
| $112K | 0.01% |
6,800
-13,200
| -66% | -$256K |
|
317
PUT
Wayfair
W
$11.9B
| $109K | 0.01% |
2,500
-50,100
| -95% | -$3.52M |
|
|
KYNB
318
CALL
Kyntra Bio
KYNB
$27.5M
| $106K | 0.01% |
400
-400
| -50% | -$102K |
|
319
Albemarle
ALB
$13.9B
| $104K | 0.01% |
+500
| New | +$112K |
|
320
TMC The Metals Company
TMC
$1.57B
| $103K | 0.01% |
100,000
| – | – |
|
321
PUT
XPeng
XPEV
$12.4B
| $102K | 0.01% |
3,200
-88,000
| -96% | -$2.26M |
|
322
Kamada
KMDA
$410M
| $99K | 0.01% |
22,000
-7,544
| -26% | -$37.3K |
|
|
CCXI
323
DELISTED
ChemoCentryx, Inc.
CCXI
| $99K | 0.01% |
+4,000
| New | +$88.2K |
|
|
DFS
324
DELISTED
Discover Financial Services
DFS
| $95K | 0.01% |
+1,000
| New | +$107K |
|
|
CVSA
325
Covista Inc
CVSA
$4.3B
| $90K | 0.01% |
2,500
-11,290
| -82% | -$356K |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q2 2022 Portfolio in Review
As of Q2 2022, SG3 Management held 1,001 positions worth $852M, down 76% from $3.56B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
SG3 Management withdrew a net $2.35B in Q2 2022, closing 613 positions and reducing 168 holdings. Its most notable exit was Amazon, an estimated $24.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, down from 2.5% a quarter earlier, followed by Energy and Technology.
Against the trend, SG3 Management opened a new position in KraneShares CSI China Internet ETF worth $6.55M.
- SG3 Management's largest Q2 2022 buy was KraneShares CSI China Internet ETF: 200,000 shares worth $6.55M.
- SG3 Management added most to Revolve Group in Q2 2022, an estimated $665K increase.
- SG3 Management's biggest Q2 2022 reduction was Bausch Health, cutting an estimated $12.4M.
- SG3 Management fully exited Amazon in Q2 2022, selling an estimated $24.8M.
- SG3 Management's ten largest holdings make up 41% of its $852M portfolio in Q2 2022.
- SG3 Management opened 100 new positions and closed 613 in Q2 2022.
- SG3 Management's portfolio value fell 76% quarter-over-quarter to $852M.
Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.